171 related articles for article (PubMed ID: 11385968)
1. Hepatitis B infection in China.
Lau GK
Clin Liver Dis; 2001 May; 5(2):361-79. PubMed ID: 11385968
[TBL] [Abstract][Full Text] [Related]
2. Current limitations to nucleoside analogue therapy for chronic hepatitis B virus infection in the liver transplant and non-transplant settings.
Freiman JS; McCaughan GW
J Gastroenterol Hepatol; 2000 Mar; 15(3):227-9. PubMed ID: 10764020
[No Abstract] [Full Text] [Related]
3. How will we use the new antiviral agents for hepatitis B?
Perrillo RP
Curr Gastroenterol Rep; 2002 Feb; 4(1):63-71. PubMed ID: 11825543
[TBL] [Abstract][Full Text] [Related]
4. [New approaches in the treatment of hepatitis B].
Sagir A; Avci A; Erhardt A; Lörke J; Heintges T; Häussinger D
Dtsch Med Wochenschr; 2004 May; 129(21):1203-8. PubMed ID: 15160325
[No Abstract] [Full Text] [Related]
5. Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.
Schiefke I; Klecker C; Maier M; Oesen U; Etzrodt G; Tannapfel A; Liebert UG; Berr F
Liver Int; 2004 Apr; 24(2):98-104. PubMed ID: 15078472
[TBL] [Abstract][Full Text] [Related]
6. Current pharmacotherapy for the treatment of chronic hepatitis B.
Lagget M; Rizzetto M
Expert Opin Pharmacother; 2003 Oct; 4(10):1821-7. PubMed ID: 14521491
[TBL] [Abstract][Full Text] [Related]
7. Nucleoside analogues for chronic hepatitis B.
Wolters LM; Niesters HG; de Man RA
Eur J Gastroenterol Hepatol; 2001 Dec; 13(12):1499-506. PubMed ID: 11742201
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy of lamivudine and famciclovir in Asian patients with chronic hepatitis B: results of 24 weeks of therapy.
Lai CL; Yuen MF; Hui CK; Garrido-Lestache S; Cheng CT; Lai YP
J Med Virol; 2002 Jul; 67(3):334-8. PubMed ID: 12116023
[TBL] [Abstract][Full Text] [Related]
9. Nucleoside analogues in the treatment of chronic hepatitis B.
Leung N
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E53-60. PubMed ID: 10921383
[TBL] [Abstract][Full Text] [Related]
10. [Current treatment of hepatitis B].
Suárez García E; Romero Gómez M; Grande Santamaría L
Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():35-50. PubMed ID: 11279893
[No Abstract] [Full Text] [Related]
11. Antiviral combination therapy for lamivudine-resistant hepatitis B reinfection after liver transplantation.
Seehofer D; Rayes N; Neuhaus R; Berg T; Müller AR; Bechstein WO; Neuhaus P
Transpl Int; 2000; 13 Suppl 1():S359-62. PubMed ID: 11112032
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B.
Fung S; Kwan P; Fabri M; Horban A; Pelemis M; Hann HW; Gurel S; Caruntu FA; Flaherty JF; Massetto B; Dinh P; Corsa A; Subramanian GM; McHutchison JG; Husa P; Gane E
Gastroenterology; 2014 Apr; 146(4):980-8. PubMed ID: 24368224
[TBL] [Abstract][Full Text] [Related]
13. Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
Delaney WE; Locarnini S; Shaw T
Antivir Chem Chemother; 2001 Jan; 12(1):1-35. PubMed ID: 11437320
[TBL] [Abstract][Full Text] [Related]
14. Comparison of different treatment combinations for chronic hepatitis B infection.
Demirtürk N; Usluer G; Ozgünes I; Colak H; Kartal ED; Dinçer S
J Chemother; 2002 Jun; 14(3):285-9. PubMed ID: 12120884
[TBL] [Abstract][Full Text] [Related]
15. Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.
Lau GK; Nanji A; Hou J; Fong DY; Au WS; Yuen ST; Lin M; Kung HF; Lam SK
J Viral Hepat; 2002 Jul; 9(4):280-7. PubMed ID: 12081605
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B in HIV patients: what is the current treatment and what are the challenges?
Soriano V; Tuma P; Vispo E; Labarga P; Fernández JV; Medrano J; Barreiro P
J HIV Ther; 2009 Mar; 14(1):13-8. PubMed ID: 19731560
[TBL] [Abstract][Full Text] [Related]
17. [Clinical management of patients with chronic hepatitis B virus infection].
Rodríguez M; González-Diéguez ML
Enferm Infecc Microbiol Clin; 2008 May; 26 Suppl 7():56-65. PubMed ID: 19100232
[TBL] [Abstract][Full Text] [Related]
18. [Famciclovir treatment of patients with chronic hepatitis B virus infection].
Li L; Shao Q; Zhang J; Ji D
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):390-1. PubMed ID: 12665916
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immune responses and loss of hepatitis B e-antigen (HBeAg) during successful lamivudine and famciclovir combination therapy for chronic replicating hepatitis B virus infection.
Hultgren C; Weiland O; Milich DR; Sällberg M
Clin Infect Dis; 1999 Dec; 29(6):1575-7. PubMed ID: 10585820
[No Abstract] [Full Text] [Related]
20. Chronic hepatitis B: interferon-monotherapy or combination with nucleoside analogues?
Tassopoulos NC
Liver; 1998 Apr; 18(2):71-2. PubMed ID: 9588765
[No Abstract] [Full Text] [Related]
[Next] [New Search]
